Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer

Carla V. Rothlin, Jonathan A Leighton, Sourav Ghosh

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Three receptor tyrosine kinases, Tyro3, Axl, and Mertk (TAM) and their ligands Gas6 and Protein S, have emerged as potent negative regulators of innate immune responses. A number of studies using genetic ablation of TAM loci in mice have elucidated the mechanism of TAM engagement and function during the immune response and removal of apoptotic cells. Following phagocytosis of apoptotic cells or the induction of T-cell dependent adaptive immune responses, ligand-induced TAM signaling dampens proinflammatory cytokine production and thus prevents exaggerated or prolonged inflammation. It is believed that the TAM pathway may play an important role in the pathogenesis of inflammatory bowel disease. Suppression of inflammation and removal of apoptotic cells followed by tissue repair are essential processes for disease remission and the successful management of inflammatory bowel disease. In light of the key role of TAMs in controlling inflammatory responses, here, we review the recent advances on TAM research vis-à-vis the resolution of intestinal inflammation. Targeted activation of TAM receptor tyrosine kinases may represent a potent therapeutic opportunity in inflammatory bowel disease.

Original languageEnglish (US)
Pages (from-to)1472-1480
Number of pages9
JournalInflammatory Bowel Diseases
Volume20
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Colitis
Inflammatory Bowel Diseases
Inflammation
Ligands
Cytophagocytosis
Neoplasms
Protein S
Adaptive Immunity
Innate Immunity
Cytokines
T-Lymphocytes
Research
axl receptor tyrosine kinase
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer. / Rothlin, Carla V.; Leighton, Jonathan A; Ghosh, Sourav.

In: Inflammatory Bowel Diseases, Vol. 20, No. 8, 2014, p. 1472-1480.

Research output: Contribution to journalArticle

@article{6fe593f851994be5b5e2297140ff2b3a,
title = "Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer",
abstract = "Three receptor tyrosine kinases, Tyro3, Axl, and Mertk (TAM) and their ligands Gas6 and Protein S, have emerged as potent negative regulators of innate immune responses. A number of studies using genetic ablation of TAM loci in mice have elucidated the mechanism of TAM engagement and function during the immune response and removal of apoptotic cells. Following phagocytosis of apoptotic cells or the induction of T-cell dependent adaptive immune responses, ligand-induced TAM signaling dampens proinflammatory cytokine production and thus prevents exaggerated or prolonged inflammation. It is believed that the TAM pathway may play an important role in the pathogenesis of inflammatory bowel disease. Suppression of inflammation and removal of apoptotic cells followed by tissue repair are essential processes for disease remission and the successful management of inflammatory bowel disease. In light of the key role of TAMs in controlling inflammatory responses, here, we review the recent advances on TAM research vis-{\`a}-vis the resolution of intestinal inflammation. Targeted activation of TAM receptor tyrosine kinases may represent a potent therapeutic opportunity in inflammatory bowel disease.",
author = "Rothlin, {Carla V.} and Leighton, {Jonathan A} and Sourav Ghosh",
year = "2014",
doi = "10.1097/MIB.0000000000000050",
language = "English (US)",
volume = "20",
pages = "1472--1480",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer

AU - Rothlin, Carla V.

AU - Leighton, Jonathan A

AU - Ghosh, Sourav

PY - 2014

Y1 - 2014

N2 - Three receptor tyrosine kinases, Tyro3, Axl, and Mertk (TAM) and their ligands Gas6 and Protein S, have emerged as potent negative regulators of innate immune responses. A number of studies using genetic ablation of TAM loci in mice have elucidated the mechanism of TAM engagement and function during the immune response and removal of apoptotic cells. Following phagocytosis of apoptotic cells or the induction of T-cell dependent adaptive immune responses, ligand-induced TAM signaling dampens proinflammatory cytokine production and thus prevents exaggerated or prolonged inflammation. It is believed that the TAM pathway may play an important role in the pathogenesis of inflammatory bowel disease. Suppression of inflammation and removal of apoptotic cells followed by tissue repair are essential processes for disease remission and the successful management of inflammatory bowel disease. In light of the key role of TAMs in controlling inflammatory responses, here, we review the recent advances on TAM research vis-à-vis the resolution of intestinal inflammation. Targeted activation of TAM receptor tyrosine kinases may represent a potent therapeutic opportunity in inflammatory bowel disease.

AB - Three receptor tyrosine kinases, Tyro3, Axl, and Mertk (TAM) and their ligands Gas6 and Protein S, have emerged as potent negative regulators of innate immune responses. A number of studies using genetic ablation of TAM loci in mice have elucidated the mechanism of TAM engagement and function during the immune response and removal of apoptotic cells. Following phagocytosis of apoptotic cells or the induction of T-cell dependent adaptive immune responses, ligand-induced TAM signaling dampens proinflammatory cytokine production and thus prevents exaggerated or prolonged inflammation. It is believed that the TAM pathway may play an important role in the pathogenesis of inflammatory bowel disease. Suppression of inflammation and removal of apoptotic cells followed by tissue repair are essential processes for disease remission and the successful management of inflammatory bowel disease. In light of the key role of TAMs in controlling inflammatory responses, here, we review the recent advances on TAM research vis-à-vis the resolution of intestinal inflammation. Targeted activation of TAM receptor tyrosine kinases may represent a potent therapeutic opportunity in inflammatory bowel disease.

UR - http://www.scopus.com/inward/record.url?scp=84905498077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905498077&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000000050

DO - 10.1097/MIB.0000000000000050

M3 - Article

C2 - 24846720

AN - SCOPUS:84905498077

VL - 20

SP - 1472

EP - 1480

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 8

ER -